Hmmmn, interesting opinion, but as yet at least, not fact. Who are we to judge without all of the facts layed before us? Still, I guess time will tell.Cheers,Gatesy
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
